BioAffinity Technologies Inc. Revenue 2022–2025
BioAffinity Technologies Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- BioAffinity Technologies Inc. revenue for the quarter ending March 31, 2026 was 1.4 M, a 27.09% decrease year-over-year.
- BioAffinity Technologies Inc. revenue for the twelve months ending March 31, 2026 was 5.9 M, a 20.56% decrease year-over-year.
- BioAffinity Technologies Inc. annual revenue for 2025 was 6.2 M, a 34.18% decrease from 2024.
- BioAffinity Technologies Inc. annual revenue for 2024 was 9.4 M, a 269.68% increase from 2023.
- BioAffinity Technologies Inc. annual revenue for 2023 was 2.5 M, a 52627.44% increase from 2022.
- BioAffinity Technologies Inc. annual revenue for 2022 was 4803.
BioAffinity Technologies Inc. (BIAF) — Frequently Asked Questions
BioAffinity Technologies Inc. (BIAF) is a publicly traded US company. It has a market capitalization of $3M. In fiscal 2025 it reported revenue of $6M and net income of -$15M. Explore BIAF's stock price, financial statements, earnings history, margins and key ratios below.
What is BioAffinity Technologies Inc.'s market cap?
BioAffinity Technologies Inc. (BIAF) has a market capitalization of $3M.
What is the BIAF stock price?
BIAF trades at $1.63 (+7.24% on the day).
How much revenue does BioAffinity Technologies Inc. make?
BioAffinity Technologies Inc. reported revenue of $6M in fiscal 2025.
Is BIAF profitable?
In fiscal 2025, BioAffinity Technologies Inc. reported net income of -$15M.